Midwest Dental Onalaska in Onalaska, Wisconsin

Info
Map & Directions
  • No Records Found

    Sorry, no records were found. Please adjust your search criteria and try again.

    Google Map Not Loaded

    Sorry, unable to load Google Maps API.

  • Dr. Michael P. Olsen, DDS

  • Dental Clinic of Onalaska

  • Smile With Uss Dental

  • Oak Forest Dental

  • Valley Dental

  • Dr. Michael Gavin, DDS

  • Aurora Bay Area Prices – FEMORAL FX W/O MANIPULATION is $735

    At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10004303, regarding FEMORAL FX W/O MANIPULATION, which is classified under revenue code 450 and associated with CPT code , the designated fee stands at $735. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.

  • |
    Aurora Sheboygan Prices – HEPATITIS B IMMUNE GLOBULIN 220 UNIT/ML IM SOLN is $278.88

    At Aurora Medical Center Sheboygan, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10002800, regarding HEPATITIS B IMMUNE GLOBULIN 220 UNIT/ML IM SOLN, which is classified under revenue code 250 and associated with CPT code 90371, the designated fee stands at $278.88. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.

  • |
    Obsessive-Compulsive Disorder (OCD): Management Strategies

    In conclusion, effective management of Obsessive-Compulsive Disorder (OCD) requires a comprehensive, multifaceted approach. Cognitive-behavioral therapy, particularly Exposure and Response Prevention (ERP), has demonstrated significant efficacy in reducing symptoms. Pharmacological interventions, primarily selective serotonin reuptake inhibitors (SSRIs), offer additional support, particularly for those with moderate to severe symptoms. Emerging treatments, such as deep brain stimulation and mindfulness-based therapies, provide promising avenues for future research and clinical application. Ultimately, a personalized treatment plan, developed in collaboration with healthcare professionals, remains crucial for optimizing outcomes and enhancing the quality of life for individuals with OCD. Continued advancements in understanding and treating OCD will undoubtedly contribute to more effective and accessible care in the years to come.